Erosion Characteristics of an Erodible Tablet Incorporated in a Time-Delayed Capsule Device

References

• Campbell, L. M. (1999). Once-daily inhaled corticosteroids in mild to moderate asthma—improving acceptance of treatment. Drugs, 58, 25–33., [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Chen, C. Pulsatile Particles Drug Delivery System. US Patent 5,260,069, November 9, 1993.
   Google Scholar
• Cooney, D. O. (1972). Effect of geometry on the dissolution of pharmaceutical tablets and other solids: surface detachment kinetics controlling. AICHE Journal, 18, 446–449., [CROSSREF]
   Web of Science ®Google Scholar
• Costa, P., Manuel, J., & Lobo, S. (2001). Modeling and comparison of dissolution profiles. European Journal of Pharmaceutical Sciences, 13(2), 123–133., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Crison, J. R., Siepmann, P. R., Taylor, M. D., & Amidon, G. L. (1995). Programmable oral release technology, PORT® system: a novel dosage form for time and site specific oral drug delivery. Proceedings of the International Symposium on Controlled Release of Bioactive Materials, 22, 278–279., [CSA]
   Google Scholar
• Durig, T., Venkatesh, G. M., & Fassihi, R. (1999). An investigation into the erosion behaviour of a high drug-load (85%) particulate system designed for an extended-release matrix tablet. Analysis of erosion kinetics in conjunction with variations in lubrication, porosity and compaction rate. Journal of Pharmacy and Pharmacology, 51(10), 1085–1092., [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Efentakis, M., & Buckton, G. (2002). The effect of erosion and swellingon the dissolution of theophylline from low and high viscosity sodium alginate matrices. Pharmaceutical Development Technology, 7(1), 69–77., [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Fyfe, C. A., & Blazek-Welsh, A. I. (2000). Quantitative NMR imaging study of the mechanism of drug release from swelling hydroxypropylmethylcellulose tablets. Journal of Controlled Release, 68(3), 313–333., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hopfenberg, H. B. (1976). Controlled release from erodible slabs, cylinders, and spheres. In D. R. Paul, & F. W. Harris, (Eds.). A.C.S. Symposium Series. Washington, D.C.: American Chemical Society,; 26–32.
   Google Scholar
• Jiang, H. L., & Zhu, K. J. (2000). Pulsatile protein release from a laminated device comprising of polyanhydrides and pH-sensitive complexes. International Journal of Pharmaceutics, 194(1), 51–60., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Katzhendler, I., Hoffman, A., Goldberger, A., & Friedman, M. (1997). Modeling of drug release from erodible tablets. Journal of Pharmaceutical Sciences, 86(1), 110–115., [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Krogel, I., & Bodmeier, R. (1998). Pulsatile drug release from an insoluble capsule body controlled by an erodible plug. Pharmaceutical Research, 15(3), 474–481., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Lemmer, B. (1989). Temporal aspects of the effects of cardiovascular active drugs in humans. In B. Lemmer, (Ed.). Chronopharmacology: Cellular and Biochemical Interactions. New York: Marcel Dekker, pp. 525–541.
   Google Scholar
• Lemmer, B. (1991). Circadian rhythms and drug delivery. Journal of Controlled Release, 16(1–2), 63–74., [CROSSREF]
   Web of Science ®Google Scholar
• McConville, J. T., Ross, A. C., Chambers, A. R., Smith, G., Florence, A. J., & Stevens, H. N. E. (2004). The effect of wet granulation on the erosion behaviour of an HPMC-lactose tablet, used as a rate-controlling component in a pulsatile drug delivery capsule formulation. European Journal of Pharmaceutics and Biopharmaceutics, 57(3), 541–549., [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• McNeill, M. E., Rashid, A., & Stevens, H. N. E. Dispensing Device. US Patent 5,342,624, August 30, 1994.
   Google Scholar
• Ross, A. C., MacRae, R. J., Walther, M., & Stevens, H. N. E. (2000). Chronopharmaceutical drug delivery from a pulsatile capsule device based on programmable erosion. Journal of Pharmacy and Pharmacology, 52(8), 903–909., [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schultz, P., & Kleinebudde, P. (1997). A new multiparticulate delayed release system. 1. Dissolution properties and release mechanism. Journal of Controlled Release, 47(2), 181–189., [CROSSREF]
   Web of Science ®Google Scholar
• Stevens, H., Chariot, M., Arnold, F., & Lewis, G. Sustained Release Pharmaceutical Composition of Diltiazem. US Patent 5,112,621, May 12, 1992.
   Google Scholar
• Sutch, J. C. D., Ross, A. C., Kockenberger, W., Bowtell, R. W., MacRae, R. J., Stevens, H. N. E., & Melia, C. D. (2003). Investigating the coating-dependent release mechanism of a pulsatile capsule using NMR microscopy. Journal of Controlled Release, 92(3), 341–347., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Ueda, S., Hata, T., Asakura, S., Yamaguchi, H., Kotani, M., & Ueda, Y. (1994). Development of a novel drug-release system, time-controlled explosion system (Tes). 1. Concept and design. Journal of Drug Targetting, 2(1), 35–44., [CSA]
   PubMed Web of Science ®Google Scholar
• Wan, L. S. C., Heng, P. W. S., & Wong, L. F. (1995). Matrix swelling—a simple model describing extent of swelling of HPMC matrices. International Journal of Pharmaceutics, 116(2), 159–168., [CROSSREF]
   Web of Science ®Google Scholar
• Wong, P. S. -LTheeuwes, F., & Larsen, S. D. Osmotic Device for Delayed Delivery of Agent. US Patent 5,312,388, May 17, 1994.
   Google Scholar
• Xu, G., & Sundana, H. (1995). Influence of formulation change on drug release kinetics from hydroxypropylmethyl cellulose matrix tablets. Chemical and Pharmaceutical Bulletin, 43(3), 483–487., [CSA]
   PubMed Web of Science ®Google Scholar
• Yano, H., Hirayama, F., Kamada, M., Arima, H., & Uekama, K. (2002). Colon-specific delivery of prednisolone-appended alpha-cyclodextrin conjugate: alleviation of systemic side effect after oral administration. Journal of Controlled Release, 79(1–3), 103–112., [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar